comprehensive
Previous article:
Psychedelics group wrestles with new pharma identity
Next article: Diverse clinical trials: Why aren’t we there yet?
Next article: Diverse clinical trials: Why aren’t we there yet?
hotspot
knowledge
-
Sage's campaign to raise awareness of postpartum depression hits a nerve
2025-09-30 17:40 -
FDA panel endorses Alnylam’s heart drug — after picking it apart
2025-09-30 17:20 -
Germany receives 178 compensation applications from gay servicepeople over discrimination
2025-09-30 17:19 -
WATCH: Why do bright lights make us see spots?
2025-09-30 16:46 -
Ohioans vote in high
2025-09-30 16:33 -
Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era
2025-09-30 15:23